First Allied Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-23,600
Closed -$1.38M 2
2015
Q1
$1.38M Buy
23,600
+2,176
+10% +$131K 0.19% 114
2014
Q4
$1.4M Sell
21,424
-319
-1% -$20.1K 0.19% 113
2014
Q3
$1.26M Buy
21,743
+2,175
+11% +$121K 0.17% 126
2014
Q2
$1.1M Buy
19,568
+1,156
+6% +$60.6K 0.16% 122
2014
Q1
$948K Sell
18,412
-110
-0.6% -$5.56K 0.14% 118
2013
Q4
$979K Buy
18,522
+251
+1% +$12.3K 0.14% 113
2013
Q3
$818K Sell
18,271
-1,103
-6% -$48.9K 0.12% 116
2013
Q2
$805K Buy
+19,374
New +$847K 0.12% 129

Other funds holding ABBV

First Allied Asset Management's ABBV Position: Q2 2015 in Review

First Allied Asset Management sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 23,600 shares — an estimated $1.38M sold.

First Allied Asset Management first reported a position in ABBV in Q2 2013 and held it in 8 quarters. The position peaked at $1.4M in Q4 2014. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • First Allied Asset Management reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • First Allied Asset Management sold 23,600 AbbVie shares in Q2 2015, an estimated $1.38M.
  • First Allied Asset Management first reported a position in AbbVie in Q2 2013 and held it in 8 quarters.
  • First Allied Asset Management's AbbVie position peaked at $1.4M in Q4 2014.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on First Allied Asset Management's 13F filing for Q2 2015.